With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support today.
FDA Says Watch Out For Fake Ozempic, A Diabetes Drug Used By Many For Weight Loss
This photo combo provided by the U.S. Food and Drug Administration shows an authentic Ozempic needle (left) and a counterfeit needle (right). The FDA said it has seized "thousands of units" of counterfeit Ozempic, the diabetes drug widely used for weight loss, that had been distributed through legitimate drug supply sources.
(
FDA via AP
)
Thousands of counterfeit units of Ozempic injections have been discovered in the legitimate supply chain and seized, the Food and Drug Administration says, but some fake products may still be in circulation.
Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic, which has become wildly popular for weight loss, is working alongside the FDA to test the seized drugs, but have yet to announce any quality or safety findings, according to a Thursday news release.
The FDA said it's "aware of five adverse events from this lot, none of which are serious and are consistent with known common adverse reactions to authentic Ozempic, which are nausea, vomiting, diarrhea, abdominal pain and constipation."
Sponsored message
The FDA is warning wholesalers, pharmacies, health care practitioners and patients alike to check their product labels for counterfeit units and report questionable products to the agency. Fakes are labeled with lot number NAR0074 and serial number 430834149057, it says.
Even the needles in the fake units are counterfeit. The FDA says it cannot confirm whether the needles are sterile or not, which poses an increased risk of infection for consumers.
Photos on the FDA news release show examples of authentic and counterfeit products so consumers can spot the fakes.
Novo Nordisk reported over $24.5 billion in sales in the first nine months of 2023, and more than one third of that is attributed to Ozempic. The weekly injection is approved for lowering blood sugar levels in patients with Type 2 diabetes. However, its increase in popularity is credited to its ability to quell food cravings via its active ingredient, semaglutide, according to the University of California-Davis.
The FDA has not approved Ozempic for weight loss, but another Novo Nordisk drug utilizing semaglutide, Wegovy, was approved in 2021 for weight management.
Copyright 2024 NPR. To see more, visit npr.org.
At LAist, we believe in journalism without censorship and the right of a free press to speak truth to those in power. Our hard-hitting watchdog reporting on local government, climate, and the ongoing housing and homelessness crisis is trustworthy, independent and freely accessible to everyone thanks to the support of readers like you.
But the game has changed: Congress voted to eliminate funding for public media across the country. Here at LAist that means a loss of $1.7 million in our budget every year. We want to assure you that despite growing threats to free press and free speech, LAist will remain a voice you know and trust. Speaking frankly, the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news in our community.
We’re asking you to stand up for independent reporting that will not be silenced. With more individuals like you supporting this public service, we can continue to provide essential coverage for Southern Californians that you can’t find anywhere else. Become a monthly member today to help sustain this mission.
Thank you for your generous support and belief in the value of independent news.
But the game has changed: Congress voted to eliminate funding for public media across the country. Here at LAist that means a loss of $1.7 million in our budget every year. We want to assure you that despite growing threats to free press and free speech, LAist will remain a voice you know and trust. Speaking frankly, the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news in our community.
We’re asking you to stand up for independent reporting that will not be silenced. With more individuals like you supporting this public service, we can continue to provide essential coverage for Southern Californians that you can’t find anywhere else. Become a monthly member today to help sustain this mission.
Thank you for your generous support and belief in the value of independent news.
Senior Vice President News, Editor in Chief
